You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API fosinopril sodium and hydrochlorothiazide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing fosinopril sodium and hydrochlorothiazide

Company Ingredient NDC Excipient
Physicians Total Care Inc fosinopril sodium and hydrochlorothiazide 54868-5346 ANHYDROUS LACTOSE
Physicians Total Care Inc fosinopril sodium and hydrochlorothiazide 54868-5346 CELLULOSE, MICROCRYSTALLINE
Physicians Total Care Inc fosinopril sodium and hydrochlorothiazide 54868-5346 CROSPOVIDONE
Physicians Total Care Inc fosinopril sodium and hydrochlorothiazide 54868-5346 POVIDONE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for fosinopril sodium and hydrochlorothiazide

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

fosinopril sodium and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Physicians Total Care Inc fosinopril sodium and hydrochlorothiazide 54868-5346
Ranbaxy Pharmaceuticals Inc fosinopril sodium and hydrochlorothiazide 63304-403
Glenmark Pharmaceuticals Inc USA fosinopril sodium and hydrochlorothiazide 68462-554
CIPLA USA INC fosinopril sodium and hydrochlorothiazide 69097-972
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CROSCARMELLOSE SODIUM

fosinopril sodium and hydrochlorothiazide drug variants not containing CROSCARMELLOSE SODIUM

Company Ingredient NDC
Physicians Total Care Inc fosinopril sodium and hydrochlorothiazide 54868-5346
Ranbaxy Pharmaceuticals Inc fosinopril sodium and hydrochlorothiazide 63304-403
Glenmark Pharmaceuticals Inc USA fosinopril sodium and hydrochlorothiazide 68462-554
CIPLA USA INC fosinopril sodium and hydrochlorothiazide 69097-972
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CROSPOVIDONE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

fosinopril sodium and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW

Company Ingredient NDC
Physicians Total Care Inc fosinopril sodium and hydrochlorothiazide 54868-5346
Ranbaxy Pharmaceuticals Inc fosinopril sodium and hydrochlorothiazide 63304-403
Glenmark Pharmaceuticals Inc USA fosinopril sodium and hydrochlorothiazide 68462-554
CIPLA USA INC fosinopril sodium and hydrochlorothiazide 69097-972
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: GLYCERYL DISTEARATE

fosinopril sodium and hydrochlorothiazide drug variants not containing GLYCERYL DISTEARATE

Company Ingredient NDC
Physicians Total Care Inc fosinopril sodium and hydrochlorothiazide 54868-5346
Ranbaxy Pharmaceuticals Inc fosinopril sodium and hydrochlorothiazide 63304-403
Glenmark Pharmaceuticals Inc USA fosinopril sodium and hydrochlorothiazide 68462-554
CIPLA USA INC fosinopril sodium and hydrochlorothiazide 69097-972
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

fosinopril sodium and hydrochlorothiazide drug variants not containing SODIUM LAURYL SULFATE

Company Ingredient NDC
Physicians Total Care Inc fosinopril sodium and hydrochlorothiazide 54868-5346
Ranbaxy Pharmaceuticals Inc fosinopril sodium and hydrochlorothiazide 63304-403
Glenmark Pharmaceuticals Inc USA fosinopril sodium and hydrochlorothiazide 68462-554
CIPLA USA INC fosinopril sodium and hydrochlorothiazide 69097-972
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM STEARATE

Excipient focus: TALC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group